Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we would like to inform that the ....

August 04, 2026 BSE Limited National Stock Exchange of India Ltd. Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai- 400 001 Mumbai- 400 051 Scrip ID-540025 Scrip Code-ADVENZYMES Dear Sir, Sub: Intimation of Conference call – Un-audited Financial Results for the quarter ended June 30, 2026 under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Company will host a Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter ended June 30, 2026 on Wednesday, August 12, 2026 at 04:00 p.m. (IST) as per the details provided in the Annexure. The aforesaid information is also being uploaded on the website of the Company. Thanking you, Yours Faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal Encl.: As above